Angiolab Inc. is an enterprise located in South Korea, with the main office in Daejeon. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on October 13, 1999. Angiolab Inc. currently employs 15 (2025) people. There was a net sales revenue increase of 10.77% reported in Angiolab Inc.’s latest financial highlights for 2025. Over the same period, its total assets grew by 18.4%. In 2025, Angiolab Inc.’s net profit margin increased by 14.36%.
Headquarters
65 Techno 3Ro, Yuseong-Gu
Daejeon; Daejeon;
Contact Details: Purchase the Angiolab Inc. report to view the information.
Website: http://www.angiolab.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service